DK1196383T3 - Fremgangsmåde til fremstilling af amlodipinbenzensulfonat - Google Patents

Fremgangsmåde til fremstilling af amlodipinbenzensulfonat

Info

Publication number
DK1196383T3
DK1196383T3 DK99933061T DK99933061T DK1196383T3 DK 1196383 T3 DK1196383 T3 DK 1196383T3 DK 99933061 T DK99933061 T DK 99933061T DK 99933061 T DK99933061 T DK 99933061T DK 1196383 T3 DK1196383 T3 DK 1196383T3
Authority
DK
Denmark
Prior art keywords
preparation
methyl
amlodipine benzenesulfonate
formula
amalodipine
Prior art date
Application number
DK99933061T
Other languages
English (en)
Inventor
Janos Fischer
Laszlo Dobay
Sandor Levai
Katalin Szoke
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of DK1196383T3 publication Critical patent/DK1196383T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK99933061T 1999-07-05 1999-07-05 Fremgangsmåde til fremstilling af amlodipinbenzensulfonat DK1196383T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (1)

Publication Number Publication Date
DK1196383T3 true DK1196383T3 (da) 2005-02-21

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99933061T DK1196383T3 (da) 1999-07-05 1999-07-05 Fremgangsmåde til fremstilling af amlodipinbenzensulfonat

Country Status (24)

Country Link
US (1) US6596874B1 (da)
EP (1) EP1196383B1 (da)
JP (1) JP3764386B2 (da)
KR (1) KR100585442B1 (da)
CN (1) CN1141297C (da)
AT (1) ATE283841T1 (da)
AU (1) AU777565B2 (da)
BG (1) BG65657B1 (da)
CA (1) CA2376540C (da)
CZ (1) CZ300509B6 (da)
DE (1) DE69922417T2 (da)
DK (1) DK1196383T3 (da)
EA (1) EA004208B1 (da)
EE (1) EE05398B1 (da)
ES (1) ES2234272T3 (da)
HK (1) HK1044151B (da)
MX (1) MXPA01013407A (da)
NO (1) NO321714B1 (da)
NZ (1) NZ517013A (da)
PL (1) PL194193B1 (da)
PT (1) PT1196383E (da)
SK (1) SK285611B6 (da)
UA (1) UA72768C2 (da)
WO (1) WO2001002360A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
EP1435954B1 (en) 2001-07-06 2010-01-13 LEK Pharmaceuticals D.D. A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
CN1352634A (zh) 2002-06-05
JP3764386B2 (ja) 2006-04-05
SK22002A3 (en) 2002-05-09
HK1044151B (zh) 2004-09-10
ES2234272T3 (es) 2005-06-16
EP1196383A1 (en) 2002-04-17
JP2003503477A (ja) 2003-01-28
NO20020029L (no) 2002-03-05
UA72768C2 (en) 2005-04-15
CN1141297C (zh) 2004-03-10
SK285611B6 (sk) 2007-04-05
CA2376540A1 (en) 2001-01-11
EA004208B1 (ru) 2004-02-26
US6596874B1 (en) 2003-07-22
NZ517013A (en) 2003-08-29
BG106164A (en) 2002-07-31
CA2376540C (en) 2007-03-13
EE05398B1 (et) 2011-04-15
NO321714B1 (no) 2006-06-26
EP1196383B1 (en) 2004-12-01
PL352493A1 (en) 2003-08-25
DE69922417D1 (de) 2005-01-05
KR100585442B1 (ko) 2006-06-02
EE200100686A (et) 2003-04-15
MXPA01013407A (es) 2003-09-04
CZ300509B6 (cs) 2009-06-03
HK1044151A1 (en) 2002-10-11
AU777565B2 (en) 2004-10-21
PL194193B1 (pl) 2007-05-31
DE69922417T2 (de) 2005-12-01
NO20020029D0 (no) 2002-01-04
CZ20014690A3 (cs) 2002-04-17
ATE283841T1 (de) 2004-12-15
WO2001002360A1 (en) 2001-01-11
BG65657B1 (bg) 2009-05-29
PT1196383E (pt) 2005-03-31
AU4923799A (en) 2001-01-22
KR20020022760A (ko) 2002-03-27
EA200200125A1 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
DK1196383T3 (da) Fremgangsmåde til fremstilling af amlodipinbenzensulfonat
DK1125924T3 (da) Mellemprodukt til syntesen af amlodipin, fremstillingsfremgangsmåde og tilsvarende anvendelse
NO20032731L (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
IS6435A (is) Aðferð til framleiðslu á sítalóprami
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
NO20002490D0 (no) FremgangsmÕte for fremstilling av 1,4-dihydropyridiner og forbindelser anvendt ved denne fremgangsmÕten
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
NO20026198D0 (no) Cykliske ketoner, deres fremstilling og deres anvendelse ved syntese av aminosyrer
DK1630169T3 (da) Mellemprodukter for LHRH-antagonist-synthesen, fremgangsmåde til deres fremstilling og fremgangsmåde til fremstilling af LHRH-antagonister
DK1282619T3 (da) Fremgangsmåde til fremstilling af thiazolidindionderivater og mellemprodukter
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
DK0994851T3 (da) Fremgangsmåde til fremstilling af 2-alkylthio-substiuerede benzoesyrederivater
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
WO2001094315A3 (en) Process for the preparation of pesticidal compounds
NO20010802L (no) Nye aryl- eller heteroarylkinolylfosfonsyreforbindelser, en fremgangsmåte ved deres fremstilling og sammensetningerinneholdende dem
DK1392652T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
DE60127979D1 (de) Verfahren zur herstellung von 3,5-bisalkylphenolen
WO1999057095A3 (en) Process for the preparation of a pharmaceutical intermediate
UA33033A (uk) Спосіб одержання безилату амлодипіну
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
DK1220867T3 (da) Fremgangsmåde til fremstilling af androst-4-en-17-carboxylsyre